![Hartoun Hartounian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hartoun Hartounian
Chief Operating Officer at BRAINSTORM CELL THERAPEUTICS INC.
Net worth: 10 140 $ as of 2024-06-29
Hartoun Hartounian active positions
Companies | Position | Start | End |
---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Chief Operating Officer | 2024-06-23 | - |
San Diego Tech Coast Angels | Corporate Officer/Principal | - | - |
Career history of Hartoun Hartounian
Former positions of Hartoun Hartounian
Companies | Position | Start | End |
---|---|---|---|
Highlander Factory, Inc.
![]() Highlander Factory, Inc. BiotechnologyHealth Technology Highlander Factory, Inc. engages in development and manufacture of cell and gene therapy. The company was founded by Haro Hartounian in 2019 and is headquartered in Newark, NJ. | Director/Board Member | 2022-04-30 | 2023-11-30 |
Chief Executive Officer | 2022-04-30 | 2023-11-30 | |
Founder | 2022-04-30 | 2023-11-30 | |
President | 2022-04-30 | 2023-11-30 | |
Vyteris, Inc.
![]() Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Director/Board Member | 2011-08-08 | 2011-08-08 |
President | - | 2011-08-08 | |
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Director/Board Member | 2006-02-16 | 2006-02-16 |
Chief Operating Officer | 2006-02-16 | 2006-02-16 | |
President | - | 2006-02-16 | |
MONSANTO | Corporate Officer/Principal | 1997-12-31 | 2000-12-31 |
PROTAGENIC THERAPEUTICS, INC. | Director/Board Member | 1994-02-02 | - |
Founder | 1994-02-02 | - | |
Protagenic Therapeutics, Inc. /Old/
![]() Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Director/Board Member | 2009-09-14 | - |
Drexel University | Corporate Officer/Principal | 2009-09-14 | - |
Training of Hartoun Hartounian
University of California, Los Angeles | Graduate Degree |
University of Delaware | Doctorate Degree |
Sharif University of Technology | Undergraduate Degree |
Statistics
International
United States | 12 |
Iran | 2 |
Operational
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
President | 3 |
Sectoral
Health Technology | 6 |
Consumer Services | 5 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
PROTAGENIC THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Monsanto Co.
![]() Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
Vyteris, Inc.
![]() Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
Protagenic Therapeutics, Inc. /Old/
![]() Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Health Technology |
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Commercial Services |
San Diego Tech Coast Angels | |
Highlander Factory, Inc.
![]() Highlander Factory, Inc. BiotechnologyHealth Technology Highlander Factory, Inc. engages in development and manufacture of cell and gene therapy. The company was founded by Haro Hartounian in 2019 and is headquartered in Newark, NJ. | Health Technology |
- Stock Market
- Insiders
- Hartoun Hartounian
- Experience